Search cutoffs
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Current report (Form 8-K) · Jun 12, 2026 · Other material event · Financial statements
| Item 8.01 | Other events the company considers material |
| Item 9.01 | Financial statements and exhibits |
Dianthus Therapeutics, Inc. /DE/ filed this to release information to investors under Regulation FD, usually a press release, conference presentation, or other event the company considers important. Advancing a leading autoimmune-focused company June 2026 Exhibit 99. 1 Forward-looking statements Certain statements in this presentation, other than purely historical information, may constitute “forward-looking statements” within the meaning of the federal securities laws, including for purposes of the safe harbor provisions under the United…
This filing reports Item 8.01 (other events the company considers material). These item codes often precede or accompany restructuring, leadership changes, or deals that can shift headcount.
Dianthus Therapeutics, Inc. /DE/ reported material events that can affect workforce planning. cutoffs surfaces the filing alongside WARN layoffs, H-1B activity, and company signals.
